154 related articles for article (PubMed ID: 9175783)
1. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme.
Ostrowska H; Wojcik C; Omura S; Worowski K
Biochem Biophys Res Commun; 1997 May; 234(3):729-32. PubMed ID: 9175783
[TBL] [Abstract][Full Text] [Related]
2. Separation of cathepsin A-like enzyme and the proteasome: evidence that lactacystin/beta-lactone is not a specific inhibitor of the proteasome.
Ostrowska H; Wójcik C; Wilk S; Omura S; Kozlowski L; Stoklosa T; Worowski K; Radziwon P
Int J Biochem Cell Biol; 2000 Jul; 32(7):747-57. PubMed ID: 10856705
[TBL] [Abstract][Full Text] [Related]
3. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
4. Lactacystin increases LDL receptor level on HepG2 cells.
Miura H; Tomoda H; Miura K; Takishima K; Omura S
Biochem Biophys Res Commun; 1996 Oct; 227(3):684-7. PubMed ID: 8885994
[TBL] [Abstract][Full Text] [Related]
5. Lactacystin inhibits cathepsin A activity in melanoma cell lines.
Kozlowski L; Stoklosa T; Omura S; Wójcik C; Wojtukiewicz MZ; Worowski K; Ostrowska H
Tumour Biol; 2001; 22(4):211-5. PubMed ID: 11399945
[TBL] [Abstract][Full Text] [Related]
6. Human platelet 20S proteasome: inhibition of its chymotrypsin-like activity and identification of the proteasome activator PA28. A preliminary report.
Ostrowska H; Ostrowska JK; Worowski K; Radziwon P
Platelets; 2003 May; 14(3):151-7. PubMed ID: 12850839
[TBL] [Abstract][Full Text] [Related]
7. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells.
Kim JM; Bae HR; Park BS; Lee JM; Ahn HB; Rho JH; Yoo KW; Park WC; Rho SH; Yoon HS; Yoo YH
J Pharmacol Exp Ther; 2003 May; 305(2):474-81. PubMed ID: 12606642
[TBL] [Abstract][Full Text] [Related]
8. The involvement of proteasome in myogenic differentiation of murine myocytes and human rhabdomyosarcoma cells.
Mugita N; Honda Y; Nakamura H; Fujiwara T; Tanaka K; Omura S; Shimbara N; Ogawa M; Saya H; Nakao M
Int J Mol Med; 1999 Feb; 3(2):127-37. PubMed ID: 9917519
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of three peptidase activities of the proteasome in human lens epithelium by heat and oxidation.
Andersson M; Sjöstrand J; Karlsson JO
Exp Eye Res; 1999 Jul; 69(1):129-38. PubMed ID: 10375457
[TBL] [Abstract][Full Text] [Related]
10. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
Demasi M; Shringarpure R; Davies KJ
Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
[TBL] [Abstract][Full Text] [Related]
11. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues.
Cardozo C; Michaud C; Orlowski M
Biochemistry; 1999 Jul; 38(30):9768-77. PubMed ID: 10423257
[TBL] [Abstract][Full Text] [Related]
12. Cathepsin A and chymotrypsin-like activity of the proteasome in human blood platelets.
Ostrowska H; Wójcik C; Worowski K
Folia Histochem Cytobiol; 1999; 37(2):153-4. PubMed ID: 10353004
[No Abstract] [Full Text] [Related]
13. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination.
Chen L; Smith L; Wang Z; Smith JB
Mol Pharmacol; 2003 Aug; 64(2):334-45. PubMed ID: 12869638
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.
Fenteany G; Standaert RF; Lane WS; Choi S; Corey EJ; Schreiber SL
Science; 1995 May; 268(5211):726-31. PubMed ID: 7732382
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic studies on the inactivation of the proteasome by lactacystin: a central role for clasto-lactacystin beta-lactone.
Dick LR; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Stein RL
J Biol Chem; 1996 Mar; 271(13):7273-6. PubMed ID: 8631740
[TBL] [Abstract][Full Text] [Related]
16. Lactacystin, proteasome function, and cell fate.
Fenteany G; Schreiber SL
J Biol Chem; 1998 Apr; 273(15):8545-8. PubMed ID: 9535824
[No Abstract] [Full Text] [Related]
17. Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats.
Itoh M; Takaoka M; Shibata A; Ohkita M; Matsumura Y
J Pharmacol Exp Ther; 2001 Aug; 298(2):501-7. PubMed ID: 11454911
[TBL] [Abstract][Full Text] [Related]
18. p27Kip1 accumulation by inhibition of proteasome function induces apoptosis in oral squamous cell carcinoma cells.
Kudo Y; Takata T; Ogawa I; Kaneda T; Sato S; Takekoshi T; Zhao M; Miyauchi M; Nikai H
Clin Cancer Res; 2000 Mar; 6(3):916-23. PubMed ID: 10741716
[TBL] [Abstract][Full Text] [Related]
19. Proteasome inhibitors.
Reboud-Ravaux M
Prog Mol Subcell Biol; 2002; 29():110-25. PubMed ID: 11908069
[No Abstract] [Full Text] [Related]
20. Cathepsin A-like activity in thrombin-activated human platelets. Substrate specificity, pH dependence, and inhibitory profile.
Ostrowska H
Thromb Res; 1997 Jun; 86(5):393-404. PubMed ID: 9211630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
